ArticleVaccines2020

A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation.

Jay Hooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.